Evidence map›Paper›PMID 30632480›Full record

ArticleMicrobiology spectrum2019

Capsular Polysaccharide of Group A

Michael R Wessels

Open access · greenAbstract read
In one paragraph

Article in Microbiology spectrum, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Development of a GFP-labeledApplied and environmental microbiology · 2026
    Article
  4. Review
  5. Article
  6. Genomic characterization and phylogenetic analysis of a clinicalFrontiers in cellular and infection microbiology · 2026
    Article
  7. Article
  8. Review
  9. Streptococcus equi subsp. equi isolated from horses in Southern Brazil: molecular and phenotypic analyses.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  10. Review
  11. ThemBio · 2025
    Article
  12. Article
  13. Article
  14. The group AInfection and immunity · 2025
    Article
  15. Review
  16. Review
  17. Clinical microbiology reviews · 2024
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Michael R WesselsDivision of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Boston Children's Hospital · US

Funding

IMMUNE RESPONSE TO THE GROUP A STREPTOCOCCAL CAPSULER01AI029952 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI WESSELS, MICHAEL R · 1991 to 2019
$5.6M
NIAID NIH HHS R01 AI029952
6 · The paper itself

Abstract

Most clinical isolates of

Indexed as

AcetylglucosamineAnimalsAntigens, BacterialBacterial AdhesionBacterial CapsulesBacterial Outer Membrane ProteinsCarrier ProteinsGlucuronic AcidHumansHyaluronan ReceptorsHyaluronic AcidPolysaccharides, BacterialStreptococcus pyogenesVirulenceVirulence FactorsAcetylglucosamineAntigens, BacterialBacterial Outer Membrane ProteinsCarrier ProteinsCD44 protein, humanGlucuronic AcidHyaluronan ReceptorsHyaluronic AcidPolysaccharides, Bacterialstreptococcal M proteinVirulence Factors

Identifiers

PMID30632480
PMCPMC6342470
OpenAlexW842411036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.